[Hematologic Malignancies/Pediatric Malignancies. Roles of Drugs Approved as New Agents and as Additional Indications for Relapse or Refractory Hematologic Malignancies]. [electronic resource]
Producer: 20160721Description: 528-9 p. digitalISSN:- 0385-0684
No physical items for this record
Publication Type: Introductory Journal Article
There are no comments on this title.
Log in to your account to post a comment.